Skip to main navigation Skip to search Skip to main content

Sleep and circadian rhythms in Parkinson’s disease and preclinical models

  • Jeremy Hunt
  • , Elizabeth J. Coulson
  • , Rajendram Rajnarayanan
  • , Henrik Oster
  • , Aleksandar Videnovic
  • , Oliver Rawashdeh
  • University of Queensland
  • University of Lübeck
  • Harvard University

Research output: Contribution to journalReview articlepeer-review

86 Scopus citations

Abstract

The use of animals as models of human physiology is, and has been for many years, an indispensable tool for understanding the mechanisms of human disease. In Parkinson’s disease, various mouse models form the cornerstone of these investigations. Early models were developed to reflect the traditional histological features and motor symptoms of Parkinson’s disease. However, it is important that models accurately encompass important facets of the disease to allow for comprehensive mechanistic understanding and translational significance. Circadian rhythm and sleep issues are tightly correlated to Parkinson’s disease, and often arise prior to the presentation of typical motor deficits. It is essential that models used to understand Parkinson’s disease reflect these dysfunctions in circadian rhythms and sleep, both to facilitate investigations into mechanistic interplay between sleep and disease, and to assist in the development of circadian rhythm-facing therapeutic treatments. This review describes the extent to which various genetically- and neurotoxically-induced murine models of Parkinson’s reflect the sleep and circadian abnormalities of Parkinson’s disease observed in the clinic.

Original languageEnglish
Article number2
JournalMolecular Neurodegeneration
Volume17
Issue number1
DOIs
StatePublished - Dec 2022

Keywords

  • Non-motor symptoms
  • Parkinson’s disease
  • RBD
  • circadian
  • insomnia
  • rapid eye movement
  • research models
  • sleep
  • sleep behavior disorder

Fingerprint

Dive into the research topics of 'Sleep and circadian rhythms in Parkinson’s disease and preclinical models'. Together they form a unique fingerprint.

Cite this